PL369077A1 - Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides - Google Patents

Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides

Info

Publication number
PL369077A1
PL369077A1 PL02369077A PL36907702A PL369077A1 PL 369077 A1 PL369077 A1 PL 369077A1 PL 02369077 A PL02369077 A PL 02369077A PL 36907702 A PL36907702 A PL 36907702A PL 369077 A1 PL369077 A1 PL 369077A1
Authority
PL
Poland
Prior art keywords
polypeptides
factor
pharmaceutical composition
factor vii
vii polypeptides
Prior art date
Application number
PL02369077A
Other languages
English (en)
Polish (pl)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Health Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care Ag filed Critical Novo Nordisk Health Care Ag
Publication of PL369077A1 publication Critical patent/PL369077A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL02369077A 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides PL369077A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101127 2001-07-20

Publications (1)

Publication Number Publication Date
PL369077A1 true PL369077A1 (en) 2005-04-18

Family

ID=8160632

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02369077A PL369077A1 (en) 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides

Country Status (16)

Country Link
EP (1) EP1411973A1 (cs)
JP (1) JP2004534855A (cs)
KR (1) KR20040015821A (cs)
CN (1) CN1304050C (cs)
AU (1) AU2002354846B2 (cs)
BR (1) BR0211256A (cs)
CA (1) CA2452677A1 (cs)
CZ (1) CZ200439A3 (cs)
HU (1) HUP0400976A3 (cs)
IL (1) IL159622A0 (cs)
MX (1) MXPA04000415A (cs)
NO (1) NO20040235L (cs)
PL (1) PL369077A1 (cs)
RU (1) RU2298416C2 (cs)
WO (1) WO2003007983A1 (cs)
ZA (1) ZA200400012B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378249A1 (en) 1999-07-14 2001-01-25 Mirella Ezban Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
ATE547519T1 (de) 2003-09-09 2012-03-15 Novo Nordisk Healthcare Ag Gerinnungsfaktor-vii-polypeptide
KR20060118486A (ko) * 2003-11-20 2006-11-23 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｘｉ의 치료적 사용
JP2007520531A (ja) * 2004-02-05 2007-07-26 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 外傷の治療のための、ＶＩＩａ因子の使用
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
US8962563B2 (en) 2009-12-21 2015-02-24 Baxter International, Inc. TFPI inhibitors and methods of use
LT2379096T (lt) 2008-12-19 2019-12-27 Baxalta GmbH Tfpi inhibitoriai ir vartojimo būdai
EP2547355B1 (en) 2010-03-19 2017-01-11 Baxalta GmbH Tfpi inhibitors and methods of use
BR112013008034A2 (pt) 2010-10-06 2016-06-14 Medimmune Ltd método para normalizar hemeostase comprometida
US20160347750A1 (en) * 2014-01-31 2016-12-01 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
US11958911B2 (en) 2017-02-10 2024-04-16 Shanghai Benemae Pharmaceutical Anti-coagulation factor XI antibody

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116213A (ja) * 1982-12-24 1984-07-05 Unitika Ltd エアゾ−ル組成物
EP0225160B1 (en) * 1985-11-26 1991-08-21 Novo Nordisk A/S Compositions and methods for the treatment of bleeding disorders
US5580560A (en) * 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
FR2676231A1 (fr) * 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
RU2214833C2 (ru) * 1994-10-24 2003-10-27 Ново Нордиск Хелс Кеар Аг Модифицированный фактор vii
IL154520A0 (en) * 2000-09-13 2003-09-17 Novo Nordisk As Human coagulation factor vii variants

Also Published As

Publication number Publication date
MXPA04000415A (es) 2004-11-22
EP1411973A1 (en) 2004-04-28
IL159622A0 (en) 2004-06-01
AU2002354846B2 (en) 2007-08-02
NO20040235L (no) 2004-03-17
RU2004105031A (ru) 2005-04-20
BR0211256A (pt) 2004-07-27
HUP0400976A3 (en) 2006-01-30
JP2004534855A (ja) 2004-11-18
CN1304050C (zh) 2007-03-14
CA2452677A1 (en) 2003-01-30
CN1556710A (zh) 2004-12-22
RU2298416C2 (ru) 2007-05-10
HUP0400976A2 (hu) 2004-08-30
WO2003007983A1 (en) 2003-01-30
KR20040015821A (ko) 2004-02-19
ZA200400012B (en) 2004-08-17
CZ200439A3 (cs) 2005-03-16

Similar Documents

Publication Publication Date Title
HUP0500989A2 (en) Animicrobial polypeptides and their uses
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
GB0117057D0 (en) Pharmaceutical composition
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
GB0108470D0 (en) Pharmaceutical compositions and their use
GB0129117D0 (en) Pharmaceutical composition
IL159872A0 (en) Gmg-2 polypeptides and their use
IL159622A0 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
GB0116107D0 (en) Pharmaceutical composition
IL161544A0 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
GB0127805D0 (en) Pharmaceutical composition
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
IL161523A0 (en) Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
GB0013503D0 (en) Pharmaceutical compositions and their uses
IL135442A0 (en) Peptides and pharmaceutical compositions comprising them
AU2002340777A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
AU2002340784A1 (en) Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides
AU2002340785A1 (en) Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides
AU2002340781A1 (en) Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides
AU2002340782A1 (en) Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors
AU2002340780A1 (en) Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)